NASDAQ:MSON - Misonix Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $16.54 +1.47 (+9.75 %) (As of 11/18/2018 04:00 PM ET)Previous Close$16.54Today's Range$15.1116 - $16.8652-Week Range$8.25 - $21.43Volume22,527 shsAverage Volume16,946 shsMarket Capitalization$157.68 millionP/E RatioN/ADividend YieldN/ABeta0.54 ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Misonix, Inc., together with its subsidiaries, designs, develops, manufactures, and markets therapeutic ultrasonic medical devices in the United States, the Americas, Europe, Middle East, Asia Pacific, Africa, and internationally. The company offers BoneScalpel, an ultrasonic bone cutting and sculpting system for surgical procedures involving the precise cutting of bone while sparing soft tissue; SonaStar, a surgical aspirator that is used to emulsify and remove soft and hard tumors primarily in the neuro and general surgery field; and SonicOne, an ultrasonic cleansing and debridement system, which provides tissue specific debridement and cleansing of wounds and burns for the removal of devitalized tissue and fibrin deposits while sparing viable cells. Its products are used in various clinical specialties, such as neurosurgery, orthopedic surgery, plastic surgery, wound care, and maxillo-facial surgical applications. The company sells its products through sales representatives and distributors. Misonix, Inc. was founded in 1959 and is based in Farmingdale, New York. Receive MSON News and Ratings via Email Sign-up to receive the latest news and ratings for MSON and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Laboratory apparatus & furniture Sub-IndustryN/A SectorComputer and Technology Current SymbolNASDAQ:MSON Previous Symbol CUSIPN/A Webwww.misonix.com Phone631-694-9555 Debt Debt-to-Equity RatioN/A Current Ratio4.61 Quick Ratio3.49 Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$36.68 million Price / Sales4.30 Cash FlowN/A Price / CashN/A Book Value$2.54 per share Price / Book6.51 Profitability EPS (Most Recent Fiscal Year)N/A Net Income$-7,610,000.00 Net Margins-23.24% Return on Equity-14.05% Return on Assets-11.75% Miscellaneous Employees118 Outstanding Shares9,530,000Market Cap$157.68 million OptionableNot Optionable Misonix (NASDAQ:MSON) Frequently Asked Questions What is Misonix's stock symbol? Misonix trades on the NASDAQ under the ticker symbol "MSON." How were Misonix's earnings last quarter? Misonix, Inc. (NASDAQ:MSON) released its earnings results on Thursday, November, 8th. The medical equipment provider reported ($0.29) earnings per share (EPS) for the quarter, missing analysts' consensus estimates of ($0.20) by $0.09. The medical equipment provider had revenue of $9.36 million for the quarter. Misonix had a negative net margin of 23.24% and a negative return on equity of 14.05%. View Misonix's Earnings History. When is Misonix's next earnings date? Misonix is scheduled to release their next quarterly earnings announcement on Tuesday, February 5th 2019. View Earnings Estimates for Misonix. What price target have analysts set for MSON? 2 brokerages have issued twelve-month target prices for Misonix's stock. Their forecasts range from $24.00 to $28.00. On average, they expect Misonix's stock price to reach $26.00 in the next year. This suggests a possible upside of 57.2% from the stock's current price. View Analyst Price Targets for Misonix. What is the consensus analysts' recommendation for Misonix? 2 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Misonix in the last year. There are currently 2 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Misonix. Has Misonix been receiving favorable news coverage? News coverage about MSON stock has trended somewhat positive recently, InfoTrie reports. The research firm scores the sentiment of press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Misonix earned a news sentiment score of 1.8 on InfoTrie's scale. They also gave headlines about the medical equipment provider a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an effect on the company's share price in the near term. Who are some of Misonix's key competitors? Some companies that are related to Misonix include Comtech Telecomm. (CMTL), IQE (IQEPF), ChipMOS Technologies (IMOS), Viomi Technology (VIOT), QAD (QADB), Ribbon Communications (RBBN), Control4 (CTRL), Quantenna Communications (QTNA), CEVA (CEVA), Sierra Wireless (SWIR), pdvWireless (PDVW), Tucows (TCX), Donnelley Financial Solutions (DFIN), Axcelis Technologies (ACLS) and Calix (CALX). Who are Misonix's key executives? Misonix's management team includes the folowing people: Mr. Stavros George Vizirgianakis, Pres, CEO & Director (Age 48)Mr. Joseph P. Dwyer, CFO, Treasurer & Sec. (Age 62)Mr. Robert Scott Ludecker, Sr. VP of Global Sales & Marketing (Age 51)Mr. Dan Voic, VP of R&D & Engineering (Age 56)Mr. Christopher H. Wright, VP of Domestic Sales (Age 43) Who are Misonix's major shareholders? Misonix's stock is owned by a variety of of institutional and retail investors. Top institutional investors include Dimensional Fund Advisors LP (3.93%), Renaissance Technologies LLC (2.46%), Bridgeway Capital Management Inc. (0.72%), Ingalls & Snyder LLC (0.65%), EAM Investors LLC (0.47%) and ClariVest Asset Management LLC (0.37%). Company insiders that own Misonix stock include Joseph P Dwyer, Patrick A Mcbrayer and Thomas M Patton. View Institutional Ownership Trends for Misonix. Which institutional investors are selling Misonix stock? MSON stock was sold by a variety of institutional investors in the last quarter, including Dimensional Fund Advisors LP. View Insider Buying and Selling for Misonix. Which institutional investors are buying Misonix stock? MSON stock was bought by a variety of institutional investors in the last quarter, including Ingalls & Snyder LLC, EAM Investors LLC, Nordea Investment Management AB, ClariVest Asset Management LLC, Renaissance Technologies LLC, Manatuck Hill Partners LLC, Bridgeway Capital Management Inc. and Acadian Asset Management LLC. Company insiders that have bought Misonix stock in the last two years include Joseph P Dwyer, Patrick A Mcbrayer and Thomas M Patton. View Insider Buying and Selling for Misonix. How do I buy shares of Misonix? Shares of MSON can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Misonix's stock price today? One share of MSON stock can currently be purchased for approximately $16.54. How big of a company is Misonix? Misonix has a market capitalization of $157.68 million and generates $36.68 million in revenue each year. Misonix employs 118 workers across the globe. What is Misonix's official website? The official website for Misonix is http://www.misonix.com. How can I contact Misonix? Misonix's mailing address is 1938 NEW HIGHWAY, FARMINGDALE NY, 11735. The medical equipment provider can be reached via phone at 631-694-9555. MarketBeat Community Rating for Misonix (NASDAQ MSON)Community Ranking: 2.4 out of 5 ( )Outperform Votes: 66 (Vote Outperform)Underperform Votes: 70 (Vote Underperform)Total Votes: 136MarketBeat's community ratings are surveys of what our community members think about Misonix and other stocks. Vote "Outperform" if you believe MSON will outperform the S&P 500 over the long term. Vote "Underperform" if you believe MSON will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 11/18/2018 by MarketBeat.com StaffFeatured Article: What are the components of an earnings report?